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Abstract
The arterial partial pressure (PCO2) of carbon dioxide is virtually constant because of the close match between the metabolic 
production of this gas and its excretion via breathing. Blood gas homeostasis does not rely solely on changes in lung ventilation, 
but also to a considerable extent on circulatory adjustments that regulate the transport of CO2 from its sites of production to the 
lungs. The neural mechanisms that coordinate circulatory and ventilatory changes to achieve blood gas homeostasis are the 
subject of this review. Emphasis will be placed on the control of sympathetic outflow by central chemoreceptors. High levels 
of CO2 exert an excitatory effect on sympathetic outflow that is mediated by specialized chemoreceptors such as the neurons 
located in the retrotrapezoid region. In addition, high CO2 causes an aversive awareness in conscious animals, activating wake-
promoting pathways such as the noradrenergic neurons. These neuronal groups, which may also be directly activated by brain 
acidification, have projections that contribute to the CO2-induced rise in breathing and sympathetic outflow. However, since the 
level of activity of the retrotrapezoid nucleus is regulated by converging inputs from wake-promoting systems, behavior-specific 
inputs from higher centers and by chemical drive, the main focus of the present manuscript is to review the contribution of central 
chemoreceptors to the control of autonomic and respiratory mechanisms.
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Cardiorespiratory integration occurs at multiple levels 
in the central nervous system (CNS) to coordinate breath-
ing and sympathetic outflow. One key example is that an 
increase in CNS arterial partial pressure of carbon dioxide 
(PCO2) (henceforth called central chemoreceptor stimula-
tion) increases breathing and sympathetic nerve activity 
(SNA) (1,2). 
Several lines of evidence suggest that brain PCO2 
is detected via changes in extracellular fluid pH, but the 
molecular and network basis of central chemoreceptors is 
still poorly understood (3). Recently, new data suggested 
that adenosine-triphosphate (ATP) could be released in re-
sponse to changes in PCO2 rather than extracellular pH and 
occurs via gap junction hemichannel connexin 36 (4).
The initial concept of specialized chemoreceptors origi-
nates from manipulations of the ventral medullary surface 
(acidification or lesions) performed since the early 1960s 
(5). More recently, focal acidification of several other brain-
stem regions in vivo (nucleus of the solitary tract (NTS), 
retrotrapezoid nucleus (RTN), raphe, pre-Bötzinger com-
plex, locus coeruleus (LC), hypothalamus) has also been 
found to activate breathing and sympathetic outflow and 
this evidence has led to the view that central chemoreceptor 
stimulation is a “distributed” property (3). 
However, one important question that remains is: how 
widely distributed is the central chemoreceptor property? Does 
each of the regions responsive to acidification contain central 
chemoreceptors involved in cardiorespiratory control?
In this short review, we consider a modern view about 
the brain areas involved in cardiorespiratory control elicited 
by central chemoreceptor stimulation. 
Role of the brainstem in cardiorespiratory 
control
Anatomically, the central interaction between the respi-
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ratory and cardiovascular systems has been extensively 
discussed in the literature (6-9). The respiratory control 
network consists of a long column of cells in the lateral 
brainstem that extends from the caudal medulla, along 
the ventrolateral medulla, to the dorsolateral pons, as well 
as to the NTS. A similar, if not overlapping, distribution of 
neurons has been identified for the cardiovascular control 
system (10,11). On the basis of functional and anatomical 
criteria, cardiovascular physiologists have divided the ven-
trolateral medulla into three rostrocaudal regions, whereas 
respiratory physiologists have divided the same area into 
four regions (Figure 1). This anatomical evidence suggests 
that the cardiovascular and respiratory systems have some 
kind of interactions at the brainstem level.
Rostral ventrolateral medulla presympathetic 
neurons as the main relay of the central 
sympathetic chemoreflex 
Normoxic hypercapnia raises blood pressure and 
activates SNA even after surgical removal of peripheral 
chemoreceptors and baroreceptors indicating that central 
chemoreceptors must be responsible for the effects of CO2 
(12,13). In anesthetized vagotomized and barodenervated 
cats, CO2 predominantly activates the phasic component 
of SNA, which happens to be synchronized with inspira-
Figure 1. Main cardiorespiratory regions of the pons and medulla. The pontomedullary neurons that regulate the heart and 
vasomotor sympathetic outflow occur in a connected structure that extends from the spinomedullary junction to the dorso-
lateral pons. This parasagittal section from a rat lies about 1.8-1.9 mm lateral to the midline. The motor outflow to diaphragm 
and intercostal and airway respiratory muscles is generated within the same brain regions. The pre-Bötzinger region (Pre-
BotC) contains neurons that are essential to inspiratory rhythm generation. A1/CPA = region containing the A1 group of no-
radrenergic neurons also called caudal pressor area; BotC = Bötzinger region; CVLM = caudal ventrolateral medulla; cVRG 
= caudal ventral respiratory group; C3-C5 = cervical spinal cord; KF = Kölliker-Fuse nucleus; LC = locus coeruleus; LPBN = 
lateral parabrachial nucleus; LRN = lateral reticular nucleus; Mo5 = mesencephalic nucleus; nA = nucleus ambiguus; NTS = 
nucleus tractus solitarii; RVLM = rostral ventrolateral medulla; RTN = retrotrapezoid nucleus; rVRG = rostral ventral respira-
tory group; T2-T8 = thoracic spinal cord; 7 = facial motor nucleus; 7n = seventh nerve.
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tion (12). These data suggest that central chemoreceptors 
activate SNA via neurons that are either part of the central 
pattern generator (CPG) or are entrained by it (Figure 2). 
The existence of CPG-independent inputs from central 
chemoreceptors to the autonomic efferents is poorly 
documented, but must be considered since in the awake 
state, SNA seems to be increased by hypercapnia more 
evenly through the respiratory cycle (13). However, the most 
plausible mechanism is that CO2 activates central chemore-
ceptors that activate the CPG, which in turn activates the 
neurons that generate the sympathetic outflow. 
In agreement with the hypothesis described above, 
the activity of the SNA doubled at steady state when 
end-expiratory CO2 rose from 5 to 10% (6,13). Central 
chemoreceptor stimulation with 10% end-expiratory CO2 
also increases by 70% the activity of the rostral ventro-
lateral medulla (RVLM) presympathetic neurons (14,15). 
Furthermore, the activation of RVLM neurons is patterned 
by the central respiratory cycle in the same manner as the 
SNA (14-16). The central respiratory pattern generator is 
important for the synchronization of the activity of presym-
pathetic RVLM neurons with respiratory activity, but not for 
the overall increase of activity of these neurons during CNS 
acidification (14,17,18)
Ionotropic glutamatergic receptor blockade in the RVLM 
eliminates SNA activation by peripheral chemoreceptors 
(14,17), whereas it does not attenuate the central sym-
pathetic chemoreflex. The effect of NMDA or non-NMDA 
Figure 2. Scheme showing the contribution of the RTN to the central sympathetic chemoreflex. Signals from cen-
tral or peripheral chemoreceptors may directly or indirectly affect the activity of several medullary areas, including 
the RTN, NTS, RVLM, and CPG, which affect sympathetic discharge to heart and blood vessels and to respira-
tory muscles. An essential step for motor neuron hypercapnia-induced phrenic nerve activity is activation of RTN 
neurons by CO2/H+, which in turn send excitatory signals to activate the CPG, either directly or through activation 
of metabotropic and ionotropic glutamate receptors in the RVLM. Signals from the RTN that activate metabotropic 
receptors in the RVLM may also increase sympathetic activity to the cardiovascular system (24). CPG = central 
pattern generator; commNTS = commissural nucleus tractus solitarii; IgluR = glutamatergic ionotropic receptors; 
MgluR = glutamatergic metabotropic receptors; RTN = retrotrapezoid nucleus; RVLM = rostral ventrolateral medulla; 
SPGn = sympathetic preganglionic neurons.
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receptor blockade inside the RVLM on the peripheral 
chemoreflex is consistent with independent anatomical 
and electrophysiological evidence that the signals from 
peripheral chemoreceptor activation reach RVLM and 
RTN neurons by a direct glutamatergic projection from the 
commissural NTS (commNTS) (19-22). The central sympa-
thetic chemoreflex was reduced by metabotropic receptor 
blockade, but not by ionotropic glutamatergic antagonists 
inside the RVLM, which suggests that central and periph-
eral chemoreflexes do not share the same mechanisms to 
produce sympathetic activation (Figure 2). 
Because the RVLM presympathetic neurons do not 
seem to be intrinsically pH-sensitive (23), their response 
to CO2 must rely on synaptic inputs, especially from RTN 
neurons that are a plausible source of CO2-dependent 
excitation (24). 
The retrotrapezoid nucleus contributes to the 
sympathoexcitation caused by hypercapnia
The tonic activation of SNA caused by hypercapnia 
in the absence of central respiratory drive suggests that 
CO2 may be detected by CNS neurons that are not part 
of the respiratory rhythm generator or by neurons that are 
normally respiratory modulated, but respond to CO2 in a 
tonic fashion when the respiratory network is silenced. The 
RTN chemoreceptor neurons fit these requirements both 
in vivo and in vitro (25-28). 
Recently, we have shown that inhibition of the chemo-
sensitive neurons located in the RTN eliminated resting 
breathing and reduced the sympathoexcitatory responses 
produced by central chemoreceptor activation (24). The 
results suggest that central chemoreceptor-induced phrenic 
nerve activity (PNA) is dependent on RTN, as previously 
demonstrated (22,24,27), whereas sympathoexcitation and 
pressor responses are only partially mediated by RTN (24). 
The reduced sympathoexcitation produced by hypercapnia 
after injection of the NMDA glutamate antagonist (AP-5) 
into the RTN, might also be the result of the decrease 
in the excitability of RVLM presympathetic neurons after 
removing baseline facilitatory glutamatergic signals from 
the RTN (Figure 2). 
RTN cells are heterogeneous with regard to respira-
tory modulation but cases of respiratory patterns that are 
identical to those of RVLM presympathetic neurons (early 
inspiratory or post-inspiratory peak) have been found, con-
sistent with the possibility that these particular RTN neurons 
drive excitatory inputs to RVLM presympathetic neurons 
(29,30). In addition, the RTN neurons are glutamatergic 
and innervate the RVLM region (25-27,31,32). 
The literature has recently discussed the involvement of 
astrocytes in the control of pH-sensitive neurons (33). There 
is increasing evidence that ATP, possibly released by astro-
cytes, is an important mediator of central chemoreception 
(34). In vivo studies have shown that hypercapnia caused 
a discrete release of ATP within the RTN (33), which might 
influence RTN neurons that signal to increase SNA through 
metabotropic receptors within the RVLM (24,33). 
Role of the pontine catecholaminergic system 
in central sympathetic chemoreflex
Noradrenergic neurons are classified as a wake-promot-
ing system that innervates the brainstem autonomic network 
(35,36). These neurons contribute to the mechanism that 
maintains breathing and sympathetic outflow during waking 
regardless of the CO2 level (32). This mechanism could be 
activated when brain CO2 reaches levels that cause arousal, 
because severe hypercapnia is an especially aversive 
stimulus in mammals (37,38). Based on this information, 
the contribution of the pontine catecholaminergic system 
to the sympathetic component of the central chemoreflex 
is plausible a priori. 
The noradrenergic neurons located in the dorsolateral 
pons (A6 - LC) and in the ventrolateral pons (A5) are mod-
estly activated by hypercapnia (39-42). The A6 neurons are 
innervated by RVLM/C1 neurons, which are CO2 responsive 
in vivo (14) and have a very wide brain projection, suggesting 
that the LC is finely tuned to regulate arousal (43).
The ventrolateral pontine A5 noradrenergic neurons 
have intrinsic properties that are very similar to those of 
the LC. A5 noradrenergic neurons have spinal projections 
that target the intermediolateral cell column and the central 
circuitry that generates the sympathetic outflow (44,45). In 
addition, these cells are activated by nociceptive stimuli, 
inhibited by the administration of alpha-2 adrenergic recep-
tor agonists and activated by hypoxia and display central 
respiratory modulation (46-49). There is some evidence 
that adrenergic A5 neurons may act as chemosensors 
for CO2, since the activity of these cells is significantly 
increased by inspired CO2 (42). In addition, stimulation of 
the A5 region with glutamate in conscious rabbits evokes 
a dose-dependent excitatory response in the renal SNA 
(50). Thus, based on the information described above, we 
could speculate that A5 noradrenergic neurons contribute 
to the activation of the sympathetic system and breathing 
by hypercapnia in rats. A5 noradrenergic neurons partially 
contribute to the increase in breathing and sympathetic 
outflow produced by raising end-expiratory CO2 in urethane-
anesthetized animals (Taxini CL, Takakura AC, Gargaglioni 
LH, Moreira TS, unpublished results) It is also reasonable 
to assume that these wake-promoting systems make a 
significant contribution to the cardiorespiratory stimula-
tion associated with several breathing disorders such as 
obstructive sleep apnea. 
Exercise and central sympathetic chemoreflex
The autonomic and respiratory mechanisms activated 
during exercise are still a mystery in physiology. Exercise 
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increases breathing, cardiac output and blood pressure. The 
large increase in cardiac output during exercise minimizes 
the changes in blood PCO2 caused by the increased meta-
bolic production of this gas. Two neural mechanisms have 
been proposed to be involved in these cardiorespiratory 
responses (51,52). First, afferent information arising from 
contracting muscle (group III and IV afferents) activates 
cardiorespiratory areas in the CNS and causes important 
cardiorespiratory changes. This has often been termed 
“exercise pressor reflex”. The second mechanism is known 
as “central command”. The “central command” consists of 
forebrain mechanisms (hypothalamic areas) that promote 
activation of medullary areas involved in cardiorespiratory 
control (53-55).
The activation of muscle metaboreceptors (group III 
and IV afferents) is responsive to the metabolic products 
of exercise (H+, lactate, K+), to muscle tension and to 
temperature. They may also respond to vessel distention, 
particularly at the muscle venule level and thus could be 
monitoring muscle blood flow by encoding the degree of 
recruitment of the muscular postcapillary network. These 
properties seem appropriate to encode the overall metabolic 
activity of muscles leading to the view that the summation 
of all locally determined perfusion rates by group III and 
IV afferents could serve as the signal needed to match 
ventilation and cardiac output to metabolic rate. The central 
pathways responsible for these effects are not known.
In decerebrate cats, locomotor activity occurs spontane-
ously or can be elicited by electrical or chemical stimulation 
of specific brain regions (i.e., hypothalamic or mesenceph-
alic “locomotor” regions). An especially detailed study by 
Eldridge et al. (51) showed that this locomotor activity is 
always associated with hyperpnea and a rise in blood 
pressure. The cardiorespiratory stimulation could not have 
been due to chemoreceptor activation since locomotion/
exercise caused a mild hypocapnia. At most, the role of 
chemoreceptors might be to limit the extent of exercise-
induced hypocapnia. The concept of a central command 
is very much in line with recent theories concerning the 
genesis of autonomic response patterns by the CNS (56), 
but current knowledge of the specific central networks that 
causes cardiorespiratory stimulation during exercise is still 
speculative. 
The hypothalamic locomotor region may overlap or be 
able to recruit the dorsomedial hypothalamic nucleus and/or 
perifornical region, which is a source of excitatory projections 
to the medulla oblongata including the presympathetic neu-
rons of the RVLM and the central chemoreceptor neurons 
of the RTN (55,57). Anatomical and physiological evidence 
suggests that the activity of RTN neurons is regulated by 
descending inputs from the hypothalamus and this pathway 
is activated during mild exercise (Falquetto B, Takakura AC, 
Moreira TS, unpublished data). This important evidence 
suggests that the chemoreceptor neurons within the RTN 
region are not just pH/ PCO2 detectors, but could also be 
regulated by synaptic inputs. 
Conclusions 
The pontomedullary region contains a set of structures 
that are essential for the reflex stabilization of arterial pres-
sure and to coordinate breathing with oxygen delivery to vari-
ous tissues. Chemoreceptor stimulation probably recruits 
a hierarchy of pathways depending on the intensity of the 
stimulus and the presence or absence of anesthesia. Mild 
stimuli such as those that regulate CO2 homeostasis under 
normal circumstances probably utilize discrete connections 
between the chemoreceptors and specific components 
of the lower brainstem cardiorespiratory network. Strong 
stimuli such as those caused by airway blockade probably 
also recruit pathways involved in stress and arousal (cat-
echolaminergic neurons). In addition, recent studies from our 
laboratory have suggested that the level of activity of RTN 
neurons is regulated by converging inputs from behavior-
specific inputs from higher centers involved in exercise.
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